Results 21 to 30 of about 10,221 (208)

The value of PRL in predicting prolactinοma in hyperprolactinemic PCOS [PDF]

open access: yes, 2018
Background To identify a serum prolactin (PRL) cut‐off value indicative of a PRL‐producing adenoma in women with Polycystic Ovarian Syndrome (PCOS) and hyperprolactinemia and characterize such patients.
Angelousi, Anna   +7 more
core   +1 more source

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy

open access: yesIndian Journal of Endocrinology and Metabolism, 2011
Management of prolactinoma in pregnancy is a big challenge for the treating obstetrician as prolactin levels are normally raised in pregnancy and this creates a possibility of missing the diagnosis of prolactinoma.
Sukhwinder Kaur Bajwa   +3 more
doaj   +1 more source

Co-Morbidity of Pituitary Adenoma and Frontal Convexity Meningioma: A Case Report and Review of the Literature

open access: yesInternational Clinical Neuroscience Journal, 2020
Instruction: The current study reports a woman with pituitary adenoma and frontal convexity meningioma that was detected accidentally. To the best of our knowledge, this case is considered as a rare clinical scenario.
Thi Phuong Hoai Dinh   +2 more
doaj   +1 more source

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas

open access: yesFrontiers in Endocrinology, 2022
BackgroundProlactinoma is the most common type of pituitary tumors, and its resultant tumor occupying and hormone disturbance greatly damage the health of patients.
Kejing Zhu   +10 more
doaj   +1 more source

Late presentation of acromegaly in medically controlled prolactinoma patients

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2016
Co-secretion of growth hormone (GH) and prolactin (PRL) from a single pituitary adenoma is common. In fact, up to 25% of patients with acromegaly may have PRL co-secretion.
Ekaterina Manuylova   +6 more
doaj   +1 more source

Giant Prolactinomas [PDF]

open access: yesNeuroendocrinology, 2018
Prolactin-secreting adenomas (prolactinomas) are the most common secreting adenomas of the pituitary. Microprolactinomas (diameter <10 mm) are frequently diagnosed in women, whereas macroprolactinomas (maximum diameter ≥10 mm) are generally seen in men. Most macroprolactinomas measure between 10 and 40 mm.
openaire   +2 more sources

A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma. [PDF]

open access: yes, 2020
Pituitary adenomas are rare in children, and often present with symptoms of headache, nausea or emesis, visual disturbance, or hormonal hypersecretion.
Amara, Dominic   +3 more
core  

Advances in the treatment of prolactinomas [PDF]

open access: yes, 2006
Prolactinomas account for approximately 40% of all pituitary adenomas and are an important cause of hypogonadism and infertility. The ultimate goal of therapy for prolactinomas is restoration or achievement of eugonadism through the normalization of ...
1997 Data on file   +627 more
core   +1 more source

Anti-c-myc efficacy block EGFL7 induced prolactinoma tumorigenesis

open access: yesOpen Chemistry, 2019
Resistance to Dopamine agonists therapy is still a key factor that hinders the clinical treatment of prolactinoma. Consequently, a large number of investigations have been carried out to identify novel therapeutic targets.
Lan Xiaolei   +4 more
doaj   +1 more source

Menstrual cycle abnormalities in patients with prolactinoma and drug-induced hyperprolactinemia

open access: yesIndian Journal of Endocrinology and Metabolism, 2017
Background and Objective: Hyperprolactinemia affects the reproductive endocrine axis; however, the degree of dysfunction may vary depending on etiology.
Bindu Kulshreshtha   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy